No health, no wealth: the cost-effectiveness and socioeconomic value of life course immunisation No health, no wealth: the cost-effectiveness and socioeconomic value of life course immunisation 1 Summary We know that the economy, and society in general, can benefit vastly from improving immunisation uptake across all age groups. [...] We held events alongside the meetings of the G7 Finance Ministers in Japan in May 2023, the meetings of the G20 Health Ministers in India in August No health, no wealth: the cost-effectiveness and socioeconomic value of life course immunisation 3 2023, and the Finance Ministers Meeting at the IMF/World Bank in Washington, USA, in April 2024. [...] The World Health Organisation (WHO) has emphasised that the next pandemic is a matter of when, not if.3 Following the COVID-19 pandemic, we have an opportunity to collectively reflect on the limitations of the global response and shift from our current curative healthcare approach to a prevention-first approach and mindset. [...] Keynote speaker at ILC ‘Economics of Longevity’ roundtable alongside the World Bank and IMF Spring Meetings in April 2024 No health, no wealth: the cost-effectiveness and socioeconomic value of life course immunisation 8 What’s happened at the G20 level since COVID-19? The COVID-19 pandemic was a time of profound change and learning within health systems, as they did their best to grapple with thi. [...] Keynote speaker at ILC G20 side-event in India in August 2024 No health, no wealth: the cost-effectiveness and socioeconomic value of life course immunisation 16 “We’ve seen in the US and in Europe that way more money, time, and effort is spent on anti-vax voices and messaging; and less on advocating for public health, and positive messaging about vaccination.
- Pages
- 20
- Published in
- United Kingdom
